Product NDC: | 57896-455 |
Proprietary Name: | Senna Plus |
Non Proprietary Name: | Sennosides and Docusate Sodium |
Active Ingredient(s): | 50; 8.6 mg/1; mg/1 & nbsp; Sennosides and Docusate Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57896-455 |
Labeler Name: | Geri-Care Pharmaceutical Corp |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20000101 |
Package NDC: | 57896-455-06 |
Package Description: | 60 TABLET in 1 BOTTLE (57896-455-06) |
NDC Code | 57896-455-06 |
Proprietary Name | Senna Plus |
Package Description | 60 TABLET in 1 BOTTLE (57896-455-06) |
Product NDC | 57896-455 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Sennosides and Docusate Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20000101 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Geri-Care Pharmaceutical Corp |
Substance Name | DOCUSATE SODIUM; SENNOSIDES |
Strength Number | 50; 8.6 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |